Explore all the latest information in myeloproliferative neoplasms, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
5-year results from the PROUD-PV and CONTINUATION-PV studies
Ropeginterferon alfa-2b is a novel pegylated recombinant interferon, approved in the EU as monotherapy for the treatment of adults with...
Results from an ongoing phase II study of IMG-7289 (bomedemstat) in patients with advanced MF
Many patients with myelofibrosis (MF) become intolerant or resistant to currently approved JAK inhibitors,...
When should we give JAK inhibitors to patients with MF in the peri-transplant setting?
During the 2021 TCT Meetings Digital Experience, the MPN Hub spoke to Ruben A. Mesa, UT Health San Antonio, San...
How should conditioning be performed before transplanting a patient with MF?
During the 2021 TCT Meetings Digital Experience, the MPN Hub spoke to Craig W. Freyer, University of Pennsylvania,...
What do we know about the outcome of concomitant MPN and COVID-19?
During the First Annual Texas Virtual MPN Workshop, the MPN Hub spoke to our Steering Committee members Laura Michaelis, Medical...
COVID-19: Implications for patients with myeloproliferative neoplasms
Summary of two presentations at the Texas Virtual MPN Workshop (TMW) 2020: First Annual Workshop and Meeting. The first from MPN...
How would you manage a young man with polycythemia vera and fatigue?
Interview with Gabriela Hobbs during the 2020 Annual Meeting of the SOHO. We asked the question: How would you manage a young man...
How can we predict and reduce the risk of thrombosis in a patient with PV?
Interview with Gabriela Hobbs during the 2020 Annual Meeting of the SOHO about reducing the risk of thrombosis in a patients...
American Association of Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European Society for Blood and Marrow Transplantation
Society of Hematologic Oncology
Texas MPN Workshop
Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR